Jonvir 150 Tablet is used in the treatment of HIV infection and chronic hepatitis B virus (HBV) infection. It prevents the multiplication of virus in human cells. This stops the virus from producing new viruses and clears up your infection.

Jonvir 150 Tablet is used in the treatment of HIV infections

Uses of Jonvir Tablet

Chronic hepatitis B virus (HBV) infection

Benefits of Jonvir Tablet

In Chronic hepatitis B virus (HBV) infection

In patients with chronic hepatitis B virus (HBV) infection, Jonvir 150 Tablet works by preventing the HBV virus from multiplying in the body. It helps control the infection and makes the immune system work better. This lowers the chances of getting complications and improves the quality of life. This medicine is always taken in combination with other antiretroviral medicines. It is not a cure and should neither be used to prevent HBV infection. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of the medicine.

Side effects of Jonvir Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Jonvir

Headache
Nausea
Diarrhea
Vomiting
Fatigue
Stomach pain
Rash

How to use Jonvir Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jonvir 150 Tablet may be taken with or without food, but it is better to take it at a fixed time.

Safety advice

Alcohol

CAUTION

Caution is advised when consuming alcohol with Jonvir 150 Tablet. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Jonvir 150 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

SAFE IF PRESCRIBED

Jonvir 150 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving

SAFE

Jonvir 150 Tablet does not usually affect your ability to drive.

Kidney

CAUTION

Jonvir 150 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jonvir 150 Tablet may be needed. Please consult your doctor.

Liver

SAFE IF PRESCRIBED

Jonvir 150 Tablet is safe to use in patients with liver disease. No dose adjustment of Jonvir 150 Tablet is recommended.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Jonvir 150 Tablet

₹10.0/Tablet

Lamivir 150 Tablet

Cipla Ltd

₹13.43/tablet

43% costlier

Heptavir 150mg Tablet

Hetero Drugs Ltd

₹9.09/tablet

3% cheaper

Lavir 150mg Tablet

Emcure Pharmaceuticals Ltd

₹9.97/tablet

6% costlier

Retrolam 150mg Tablet

Alkem Laboratories Ltd

₹9.18/tablet

2% cheaper

Lamimat 150mg Tablet

Mylan Pharmaceuticals Pvt Ltd

₹10/tablet

6% costlier

View all substitutes

Quick tips

You have been prescribed Jonvir 150 Tablet for the treatment of chronic hepatitis B virus (HBV) infection.
In combination with other medicines, it is used for the treatment of HIV infections.
Take it with food, as this increases the absorption of the medicine into the body.
Jonvir 150 Tablet may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
You may still develop infections or other illnesses associated with viral infection while taking this medication.
You can also pass on HIV or HBV to others. Don't share needles or personal items that can have blood or body fluids on them.
During treatment and for at least six months after stopping this medicine, regular blood tests are needed to monitor your liver function, level of hepatitis B virus and blood cells in your blood.

Fact Box

Chemical Class

Nucleoside analog

Habit Forming

Therapeutic Class

ANTI INFECTIVES

Action Class

Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)

Patient concerns

I have HBV related chronic liver problem .Local urologist suggest me to take rapilif d 8 for urine block problem?Can i take that medicine with entavir for hepatitis b virus and cronic liver disease?

Dr. Praveen Pushkar

Urology

Yes u can take it

Suffering from Hepatitis B virus from last one week. Please suggest me.

Dr. Anshum Aneja Arora

Pulmonology

Pls consult a gastroenterologist

FAQs

How should I take Jonvir 150 Tablet?

Jonvir 150 Tablet should be taken in the dose and duration advised by the doctor. This medicine can be taken with or without food. However, it is better to take it at a fixed time of the day to avoid the chances of missing a dose.

Is Jonvir 150 Tablet effective?

Jonvir 150 Tablet is effective if used in the dose and duration advised by your doctor. Do not stop taking it even if you see improvement in your condition. If you stop using Jonvir 150 Tablet too early, the symptoms may return or worsen.

What is drug resistance? Can I develop drug resistance with Jonvir 150 Tablet?

Drug resistance is a state where the medicine which was once effective in treating an infection becomes ineffective. This mainly happens due to the ability acquired by the virus or bacteria to get modified inside the body which affects the overall working of the medicine. Hence, the medicine is no longer able to fight against the virus or bacteria. Generally, drug resistance with Jonvir 150 Tablet is more likely to happen if you take less dose than what is recommended.

How long should I take Jonvir 150 Tablet?

Do not stop taking entecavir without consulting your doctor. Stopping entecavir before treatment may worsen your hepatitis. This can happen during the first several months after you stop taking entecavir. Take the medicine strictly as advised and do not miss any dose.

What if I forget to take a dose of Jonvir 150 Tablet?

If you forget a dose of Jonvir 150 Tablet, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take the next scheduled dose in the prescribed time. Do not double the dose to make up for the missed one as this may increase the chances of developing side effects.

What if HIV infection co-exists with HBV infection? Will this affect treatment with Jonvir 150 Tablet?

In HBV patients who are diagnosed with HIV, Jonvir 150 Tablet is not recommended until and unless these patients start taking medicines for HIV management. Starting Jonvir 150 Tablet in such patients may cause resistance to the prescribed HIV medicines. Therefore, doctors recommend tests for HIV in patients diagnosed with HBV infection before starting treatment with Jonvir 150 Tablet.

Can Jonvir 150 Tablet cure hepatitis B?

No, Jonvir 150 Tablet does not cure hepatitis B but may improve the condition of the liver. It may decrease the amount of hepatitis B virus (HBV) present in the body. This is done by limiting the ability of HBV to multiply and further infect new liver cells.

Is Jonvir 150 Tablet safe?

Jonvir 150 Tablet is safe if used in the dose and duration advised by your doctor. Take it exactly as directed and do not skip any dose. Follow your doctor's instructions carefully and let your doctor know if any of the side effects bother you.

Show less

Related lab tests

Hepatitis B (Core) IgM Antibody

Hepatitis B s (Surface) Antigen

Hepatitis C Virus Total Antibody

Top Physicians

4.9 ★

4.3 ★

4.6 ★

4.1 ★

4.2 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Acosta EP, Flexner C. Antiviral Agents (Nonretroviral). In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1617-618.
Safrin S. Antiviral Agents. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 858, 869-70.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 767-70.
Lamivudine. South Ruislip, Middlesex: Aurobindo Pharma - Milpharm Ltd.; 2012 [revised 24 Jun. 2018]. (online) Available from:
Drugs.com. Lamivudine. [Accessed 31 Mar. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 31 Mar. 2019] (online) Available from:

Marketer details

Name: Johnlee Pharmaceuticals Pvt Ltd

Address: 42/44, Babu Genu Road, Shop No. 06, 2nd Floor, Om Shanti Co-op Housing Society, Kalbadevi Road, Mumbai-400002. (India)

Country of origin: India
Expires on or after: February, 2025

A licensed vendor partner from your nearest location will deliver Jonvir 150 Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.

In case of any issues, contact us

Email ID: [email protected]
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India

16 people viewed this recently

MRP

₹300

Inclusive of all taxes

30.0 tablets in 1 bottle

Add to cart

We provide you with authentic, trustworthy and relevant information

Have issue with the content?